Previsioni di mercato del biobanking e rapporto di ricerca sulla domanda fino al 2030</font></font>

Name: Mercato delle biobanche per prodotto (attrezzature, materiali di consumo, servizi, software), per tipo di campione (prodotti sanguigni, tessuti umani, linee cellulari, acidi nucleici), per applicazione (medicina rigenerativa, scienze della vita, ricerca clinica) e regione, tendenze globali e previsioni dal 2023 al 2030.
Price: 3499 USD
Availability: InStock
Rating: 4.5 (92 reviews)
Author: Exactitude Consultancy
ISBN: 29990

Panoramica del mercato della biobanca

Si prevede che il mercato delle biobanche crescerà al 7,9% di CAGR dal 2023 al 2030. Si prevede che raggiungerà oltre 48,33 miliardi di USD entro il 2030 dai 28,80 miliardi di USD nel 2023.

Il processo di raccolta, conservazione e gestione di campioni biologici e dati associati per l'uso in applicazioni di ricerca e terapeutiche è denominato biobanking. Le biobanche possono raccogliere una varietà di campioni, come sangue, tessuti e fluidi corporei, nonché dati clinici, come anamnesi e dati sullo stile di vita. Questi campioni e dati sono spesso conservati in biobanche, che sono strutture specializzate.

Le biobanche sono sempre più utilizzate nella ricerca biomedica e nei trattamenti personalizzati. Le biobanche forniscono ai ricercatori l'accesso a grandi e diversificate raccolte di campioni biologici e dati, che possono aiutare nella scoperta di biomarcatori per la rilevazione e la diagnosi delle malattie , nello sviluppo di trattamenti personalizzati basati sul corredo genetico di un individuo e nel progresso della medicina di precisione. Le biobanche pongono anche problemi etici e legali sulla raccolta, la conservazione e l'utilizzo dei campioni, come la privacy dei donatori e il requisito di un'autorizzazione informata.

[caption id="allegato_30006" align="aligncenter" width="1920"] Biobanking Market | Exactitude Consultancy

Mercato delle biobanche | Exactitude Consultancy[/didascalia]

Il crescente desiderio di un trattamento personalizzato è uno dei principali motori del biobanking. Con una maggiore comprensione delle differenze individuali in genetica, stile di vita e variabili ambientali, la medicina personalizzata sta diventando sempre più cruciale per la prevenzione e il trattamento delle malattie. Le biobanche sono un'importante fonte di dati e campioni biologici per lo sviluppo della medicina personalizzata e si prevede che la domanda di servizi di biobanking aumenterà negli anni a venire.

La crescente prevalenza di malattie croniche come cancro, diabete e malattie cardiovascolari è un altro motore del business delle biobanche. Queste malattie rappresentano un peso considerevole per i sistemi sanitari a livello globale e si prevede che la loro prevalenza aumenterà nei prossimi anni con l'invecchiamento della popolazione e il cambiamento degli stili di vita. I ricercatori possono utilizzare le biobanche per esaminare le cause sottostanti di vari disturbi, scoprire biomarcatori per la diagnosi e la diagnosi precoce e sviluppare nuovi trattamenti.

The expense of collecting, storing, and managing biological samples and data is one possible market barrier for biobanking. Biobanks necessitate large expenditures in infrastructure, equipment, and employees, which might be prohibitively expensive for smaller organizations or research institutes with limited resources. Furthermore, ethical and legal problems about privacy, ownership, and consent may complicate the process of obtaining and using biological samples for research purposes.

The high cost of adopting and maintaining these systems is a major limitation in the Biobanking business. The initial investment in technology and software can be substantial, particularly for smaller healthcare facilities. Furthermore, the complexity of these systems can result in increased training costs and potential user adoption concerns. Concerns about regulatory and data privacy can also be a problem, especially with the rising usage of cloud-based solutions and the need to comply with various data protection standards.

The COVID-19 pandemic has had an impact on the biobanking sector, both positively and negatively. On the one hand, the pandemic has boosted the focus on vaccine and treatment research and development, raising demand for biobanking services and samples. On the other side, supply chain interruptions, restrictions on research efforts, and budget cuts have all had a detrimental impact on the market. In reaction to the epidemic, there has also been a shift towards virtual biobanking systems, as well as a greater emphasis on data management and sharing.

ATTRIBUTE	DETAILS
Study period	2020-2030
Base year	2022
Estimated year	2023
Forecasted year	2023-2030
Historical period	2019-2021
Unit	Value (USD Billion)
Segmentation	By Product, By Sample Type, By Application, By Region
By Product	Equipment Consumables Services Software
By Sample Type	Blood Products Human Tissues Cell Lines Nucleic Acids
By Application	Regenerative Medicine Life Science Clinical Research
By Region	North America Asia Pacific Europe South America Middle East Asia & Africa

Frequently Asked Questions

• What is the worth of medical biobanking market?

The biobanking is expected to grow at 7.9% CAGR from 2023 to 2030. It is expected to reach above USD 44.6 billion by 2029 from USD 22.5 billion in 2020.

• What is the size of the north america medical biobanking market industry?

North America held more than 47% of the biobanking revenue share in 2022 and will witness expansion in the forecast period.

• What are some of the biobanking market's driving forces?

The growing desire for personalised treatment is one of the primary drivers of biobanking. With an increased understanding of individual differences in genetics, lifestyle, and environmental variables, personalised medicine is becoming increasingly crucial for illness prevention and treatment. Biobanks are an important source of data and biological samples for the development of personalised medicine, and demand for biobanking services is projected to increase in the future years.

• Which are the top companies to hold the market share in medical biobanking market?

The Biobanking key Thermo Fisher Scientific, Qiagen, Hamilton Company, Brooks Life Sciences, Tecan Group, VWR International, Promega Corporation, Chart Industries, Bio Life Solutions, Panasonic Healthcare Holdings, Micronics.

• What is the leading product of biobanking market?

Based on product, the biobanking market can be segmented based on equipment, consumables, services, and software. The equipment segment includes freezers, storage systems, and sample management systems. The consumables segment includes storage tubes, sample containers, and other consumables. The services segment includes biorepository, sample processing, and storage services. The software segment includes data management and inventory management software.

• Which is the largest regional market for biobanking market?

The North America region dominated the biobanking by accounting for over 47% of the market share. The biobanking market in North America is expected to grow significantly in the coming years due to increasing investment in research and development activities, advancements in personalized medicine, and rising demand for high-quality biological samples. The United States dominates the market due to its well-established healthcare infrastructure, favorable regulatory policies, and high healthcare spending. Key players in the North American biobanking market include Thermo Fisher Scientific, Qiagen, Incision, and Hamilton Company, among others.

Biobanking Market Segment Analysis

The biobanking market is segmented based on product, sample type, application, and region. [caption id="attachment_30010" align="aligncenter" width="1920"]

Biobanking Market | Exactitude Consultancy[/caption] Based on product, the biobanking market can be segmented based on equipment, consumables, services, and software. The equipment segment includes freezers, storage systems, and sample management systems. The consumables segment includes storage tubes, sample containers, and other consumables. The services segment includes biorepository, sample processing, and storage services. The software segment includes data management and inventory management software. Based on sample type, the biobanking market can be segmented based on the type of biological samples stored, including blood products, human tissues, cell lines, and nucleic acids. Blood products segment holds the largest market share due to the rising demand for blood and blood-based products for research and therapeutic purposes. The human tissues segment is expected to grow rapidly due to increased focus on personalized medicine. [caption id="attachment_30012" align="aligncenter" width="1920"]

Biobanking Market | Exactitude Consultancy[/caption] Based on application, the biobanking market can be segmented based on its applications, including clinical research, regenerative medicine, drug discovery, and bioburden testing. Clinical research is the largest application segment, followed by regenerative medicine. The drug discovery segment is expected to show the fastest growth due to the increasing demand for personalized medicine [caption id="attachment_30014" align="aligncenter" width="1920"]

Biobanking Market | Exactitude Consultancy[/caption]

Biobanking Market Players

The biobanking market key market players are Thermo Fisher Scientific, Qiagen, Hamilton Company, Brooks Life Sciences, Tecan Group, VWR International, Promega Corporation, Chart Industries, Bio Life Solutions, Panasonic Healthcare Holdings, Micronics. Industry Development

24-April -2023: - QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced on a specific date in the past that its QIAstat-Dx syndromic testing solution was expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory Panel that could detect more than 20 pathogens from a single patient sample.
05-Januray-2023: - QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced an exclusive strategic partnership with California-based population genomics leader Helix to advance companion diagnostics for hereditary diseases in the past..

Who Should Buy? Or Key stakeholders

Researchers
Government
Medical Professionals
Medical Instruments
Clinical Laboratories
Clinics
Others

Biobanking Market Regional Analysis

The biobanking market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

The North America region dominated the biobanking by accounting for over 47% of the market share. The biobanking market in North America is expected to grow significantly in the coming years due to increasing investment in research and development activities, advancements in personalized medicine, and rising demand for high-quality biological samples. The United States dominates the market due to its well-established healthcare infrastructure, favorable regulatory policies, and high healthcare spending. Key players in the North American biobanking market include Thermo Fisher Scientific, Qiagen, Incision, and Hamilton Company, among others.

[caption id="attachment_30015" align="aligncenter" width="1920"]

Biobanking Market | Exactitude Consultancy[/caption]

The biobanking market in Europe is projected to grow at a compound annual growth rate of 7.4% from 2023 to 2030. This growth is driven by the increasing demand for personalized medicine, advancements in biobanking technology, and the rising prevalence of chronic diseases. The UK, Germany, and France are the leading countries in the European biobanking market.

Key Market Segments: Biobanking market

Biobanking by Product, 2020-2030, (USD Billion)

Equipment
Consumables
Services
Software

Biobanking by Sample Type, 2020-2030, (USD Billion)

Blood Products
Human Tissues
Cell Lines
Nucleic Acids

Biobanking by Application, 2020-2030, (USD Billion)

Regenerative Medicine
Life Science
Clinical Research

Biobanking by Region, 2020-2030, (USD Billion)

North America
Asia Pacific
Europe
South America
Middle East and Africa

Important Countries in All Regions Are Covered.

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered

What is the expected growth rate of the biobanking market over the next 7 years?
Who are the major players in the biobanking market and what is their market share?
What are the application industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, And Africa?
How is the economic environment affecting the biobanking market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the biobanking market?
What is the current and forecasted size and growth rate of the global biobanking market?
What are the key drivers of growth in the biobanking market?
Who are the major players in the market and what is their market share?
What are the distribution channels and supply chain dynamics in the biobanking market?
What are the technological advancements and innovations in the biobanking market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the biobanking market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the biobanking market?
What are the service offerings and specifications of leading players in the market?
What is the pricing trend of biobanking market in the market and what is the impact of raw process prices on the price trend?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS

RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES

EXECUTIVE SUMMARY

MARKET OVERVIEW
1. GLOBAL BIOBANKING OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON BIOBANKING MARKET
3. PORTER’S FIVE FORCES SAMPLE TYPEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS

GLOBAL BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030
1. EQIPMENT
2. CONSUMABLES
3. SERVICES
4. SOFTWARE

GLOBAL BIOBANKING MARKET BY SAMPLE TYPE (USD BILLION) 2020-2030
1. BLOOD PRODUCTS
2. HUMAN TISSUES
3. CELL LINES
4. NUCLEIC ACIDS

GLOBAL BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030
1. REGENERATIVE MEDICINE
2. LIFE SCIENCE
3. CLINICAL RESEARCH

GLOBAL BIOBANKING MARKET BY REGION (USD BILLION) 2020-2030
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES*

(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

THERMO FISHER SCIENTIFIC

QIAGEN

HAMILTON COMPANY

BROOKS LIFE SCIENCES

TECAN GROUP

VWR INTERNATIONAL

PROMEGA CORPORATION

CHART INDUSTRIES

BIO LIFE SOLUTIONS

PANASONIC HEALTHCARE HOLDINGS

MICRONICS

*THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 2 GLOBAL BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 3 GLOBAL BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 4 GLOBAL BIOBANKING MARKET BY REGION (USD BILLION) 2020-2030

TABLE 5 NORTH AMERICA BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 6 NORTH AMERICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 7 NORTH AMERICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 8 NORTH AMERICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 9 US BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 10 US BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 11 US BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 12 CANADA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 13 CANADA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 14 CANADA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 15 MEXICO BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 16 MEXICO BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 17 MEXICO BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 18 SOUTH AMERICA BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 19 SOUTH AMERICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 20 SOUTH AMERICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 21 SOUTH AMERICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 22 BRAZIL BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 23 BRAZIL BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 24 BRAZIL BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 25 ARGENTINA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 26 ARGENTINA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 27 ARGENTINA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 28 COLOMBIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 29 COLOMBIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 30 COLOMBIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 31 REST OF SOUTH AMERICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 32 REST OF SOUTH AMERICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 33 REST OF SOUTH AMERICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 34 ASIA-PACIFIC BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 35 ASIA-PACIFIC BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 36 ASIA-PACIFIC BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 37 ASIA-PACIFIC BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 38 INDIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 39 INDIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 40 INDIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 41 CHINA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 42 CHINA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 43 CHINA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 44 JAPAN BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 45 JAPAN BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 46 JAPAN BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 47 SOUTH KOREA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 48 SOUTH KOREA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 49 SOUTH KOREA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 50 AUSTRALIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 51 AUSTRALIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 52 AUSTRALIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 53 SOUTH-EAST ASIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 54 SOUTH-EAST ASIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 55 SOUTH-EAST ASIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 56 REST OF ASIA PACIFIC BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 57 REST OF ASIA PACIFIC BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 58 REST OF ASIA PACIFIC BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 59 EUROPE BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 60 EUROPE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 61 EUROPE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 62 EUROPE C BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 63 GERMANY BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 64 GERMANY BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 65 GERMANY BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 66 UK BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 67 UK BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 68 UK BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 69 FRANCE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 70 FRANCE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 71 FRANCE BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 72 ITALY BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 73 ITALY BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 74 ITALY BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 75 SPAIN BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 76 SPAIN BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 77 SPAIN BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 78 RUSSIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 79 RUSSIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 80 RUSSIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 81 REST OF EUROPE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 82 REST OF EUROPE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 83 REST OF EUROPE BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 84 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 85 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 86 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 87 MIDDLE EAST AND AFRICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 88 UAE BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 89 UAE BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 90 UAE BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 91 SAUDI ARABIA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 92 SAUDI ARABIA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 93 SAUDI ARABIA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 94 SOUTH AFRICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 95 SOUTH AFRICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 96 SOUTH AFRICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

TABLE 97 REST OF MIDDLE EAST AND AFRICA BIOBANKING MARKET BY PRODUCT (USD BILLION) 2020-2030

TABLE 98 REST OF MIDDLE EAST AND AFRICA BIOBANKING MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 99 REST OF MIDDLE EAST AND AFRICA BIOBANKING MARKET BY SMAPLE TYPE (USD BILLION) 2020-2030

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL BIOBANKING BY PRODUCT, USD BILLION, 2020-2030

FIGURE 9 GLOBAL BIOBANKING BY CELL TYPE, USD BILLION, 2020-2030

FIGURE 10 GLOBAL BIOBANKING BY END-USER, USD BILLION, 2020-2030

FIGURE 11 GLOBAL BIOBANKING BY REGION, USD BILLION, 2020-2030

FIGURE 12 GLOBAL BIOBANKING BY PRODUCT, USD BILLION, 2022

FIGURE 13 GLOBAL BIOBANKING BY CELL TYPE, USD BILLION, 2022

FIGURE 14 GLOBAL BIOBANKING BY END-USER, USD BILLION, 2022

FIGURE 15 GLOBAL BIOBANKING BY REGION, USD BILLION, 2022

FIGURE 16 PORTER’S FIVE FORCES SMAPLE TYPEL

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 19 QIAGEN: COMPANY SNAPSHOT

FIGURE 20 HAMILTON COMPANY: COMPANY SNAPSHOT

FIGURE 21 BROOKS LIFE SCIENCES: COMPANY SNAPSHOT

FIGURE 22 TECAN GROUP: COMPANY SNAPSHOT

FIGURE 23 VWR INTERNATIONAL: COMPANY SNAPSHOT

FIGURE 24 PROMEGA CORPORATION: COMPANY SNAPSHOT

FIGURE 25 CHART INDUSTRIES: COMPANY SNAPSHOT

FIGURE 26 BIO LIFE SOLUTIONS: COMPANY SNAPSHOT

FIGURE 27 PANASONIC HEALTHCARE HOLDINGS: COMPANY SNAPSHOT

FIGURE 28 MICRONICS: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Biobanking Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Panoramica del mercato della biobanca

Frequently Asked Questions

• What is the worth of medical biobanking market?

• What is the size of the north america medical biobanking market industry?

• What are some of the biobanking market's driving forces?

• Which are the top companies to hold the market share in medical biobanking market?

• What is the leading product of biobanking market?

• Which is the largest regional market for biobanking market?

Biobanking Market Segment Analysis

Biobanking Market Players

Who Should Buy? Or Key stakeholders

Biobanking Market Regional Analysis

Key Market Segments: Biobanking market

Exactitude Consultancy Services Key Objectives:

Key Question Answered

LIST OF TABLES

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept